Browsing by Author Man, PS

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 4 to 22 of 22 < previous 
TitleAuthor(s)Issue DateViews
 
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer
Journal:International Journal of Molecular Sciences
Tsoi, HTSANG, WCMan, PSLeung, MHYou, CChan, SYChan, WLWKhoo, US
2022
 
Combined use of Ivabradine and Olaparib as a novel therapeutic strategy for triple-negative breast cancer
Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021
Leung, MHTsoi, HMan, PSGong, CKhoo, US
2021
 
Dual-utility NLS drives RNF169-dependent DNA damage responses
Journal:Proceedings of the National Academy of Sciences
An, LJiang, YNg, HLLMan, PSChen, JKhoo, USGong, QHuen, MSY
2017
104
 
FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
Journal:Oncogene
Khongkow, PKarunarathna, UKhongkow, MGong, CGomes, ARYague, EMonteiro, LJKongsema, MZona, SMan, PSTsang, JWHCoombes, RCWu, KJKhoo, USMedema, RHFreire, RLam, EW
2014
84
 
Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1
Journal:Nature Genetics
Cai, QZhang, BSung, HLow, SKKweon, SSLu, WShi, JLong, JWen, WChoi, JYNoh, DYShen, CYMatsuo, KTeo, SHKim, MKKhoo, USIwasaki, MHartman, MTakahashi, AAshikawa, KMatsuda, KShin, MHPark, MHZheng, YXiang, YBJi, BTPark, SKWu, PEHsiung, CNIto, HKasuga, YKang, PMariapun, SAhn, SHKang, HSChan, YKMan, PSIwata, HTsugane, SMiao, HLiao, JNakamura, YKubo, MConsortium, DGDelahanty, RJZhang, YLi, BLi, CGao, YTShu, XOKang, DZheng, W
2014
 
Hyperpolarization-activated cyclic nucleotide-gated channel (HCN) blocker, Ivabradine, a novel potential targeted treatment for triple-negative breast cancer.
Proceeding/Conference:European Journal of Cancer
Khoo, USMok, KCTsoi, HMan, PSChau, KMLee, TKGong, C
2018
 
Identification of estrogen receptor-alpha as a new translational target of e1F4E
Proceeding/Conference:2nd CSH Asia Conference on RNA Biology
Gong, CCheung, YNWong, SYMan, PSYang, NTsang, WHKhoo, US
2012
 
KPNA1 mediates the nuclear import of BQ323636.1 and confer tamoxifen resistance in breast cancer cells
Proceeding/Conference:Cancer Research
Mok, KCTsoi, HChou, KMKhoo, USMan, PS
2018
57
 
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer
Journal:Clinical and Translational Medicine
Tsoi, HMan, PSLeung, MHMOK, KCChau, KMWong, LSChan, WLWChan, SYLuk, MYCheng, CNKhoo, US
2021
 
Modulating the Activity of Androgen Receptor for Treating Breast Cancer
Journal:International Journal of Molecular Sciences
You, CTsoi, HMan, PSLeung, MHKhoo, US
2022
 
OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance
Journal:Oncogene
Karunarathna, UKongsema, MZona, SGong, CCabrera, EGomes, ARMan, PSKhongkow, PTsang, JWHKhoo, USMedema, RHFreire, RLam, EW
2015
100
 
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer
Journal:Life
Tsoi, HSHI, LLeung, MHMan, PSSo, ZQChan, WLWKhoo, US
2022
6
 
Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
Journal:Oncogene
Khongkow, PGomes, ARGong, CMan, PSTsang, JWHZhao, FMonteiro, LJCoombes, RCMedema, RHKhoo, USLam, EW
2015
 
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer
Journal:Clinical and Translational Medicine
MOK, KCTsoi, HMan, PSLeung, MHChau, KMWong, LSChan, WLWChan, SYLuk, MYChan, YWLeung, KMChan, HYSilva Coimbra Batalha, SLLau, VYMSiu, DCWLee, KWGong, CKhoo, US
2021
 
RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment
Journal:Oncogenesis
Kongsema, MZona, SKarunarathna, UCabrera, EMan, PSYao, SShibakawa, AKhoo, USMedema, RHFreire, RLam, EW
2016
71
 
Targeting androgen receptor in BQ323636.1 overexpressing ER+ breast cancer to overcome aromatase inhibitor resistance
Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021
Lok, JTsoi, HMan, PSChan, WLWChan, SYCheng, CNKhoo, US
2021
 
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer
Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021
Tsoi, HMan, PSTSANG, WCWong, LSChan, WLWChan, SYKhoo, US
2021
 
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer
Journal:Cancers
Tsoi, HYOU, CLeung, MHMan, PSKhoo, US
2022
2
 
Translational regulation by eIF4E and its contribution to tamoxifen resistance in breast cancer
Proceeding/Conference:Cancer Research
Gong, CMok, KCCheung, YNMan, PSLam, EWFKhoo, US
2016
71
Showing results 4 to 22 of 22 < previous